Regulation of human erythropoiesis
人类红细胞生成的调节
基本信息
- 批准号:10228572
- 负责人:
- 金额:$ 29.12万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1997
- 资助国家:美国
- 起止时间:1997-01-30 至 2024-07-31
- 项目状态:已结题
- 来源:
- 关键词:AnemiaApoptosisApoptoticAttentionBFU-EBioinformaticsBiologicalBiological AssayCFU-ECell Differentiation processCell membraneCellsCellular MorphologyCellular biologyClinicalCollaborationsComplexCooley&aposs anemiaCytokinesisDataDefectDevelopmentDiamond-Blackfan anemiaDiseaseDysmyelopoietic SyndromesEpigenetic ProcessErythroblastsErythrocytesErythroidErythroid CellsErythropoiesisEventGene ExpressionGene Expression ProfileGenerationsGenesGenomicsGlucoseGlutamineGoalsHealthHematological DiseaseHematopoietic stem cellsHeterogeneityHumanImpairmentKnowledgeLaminsLeadLinkMetabolismMethodsMitosisMitosis InductionMolecularMutateOncogene DeregulationParentsPopulationPopulation AnalysisProcessProductionProliferatingRegulationResearchResearch Project GrantsRestReticulocytesRibosomal ProteinsRoleTestingUp-Regulationbasebiological heterogeneitybone marrow failure syndromedaughter celleffective therapyerythroid differentiationglobal healthimprovedinsightknock-downmannovelnovel therapeutic interventionprogenitorsingle-cell RNA sequencingsynergismtranscriptome sequencingvalidation studies
项目摘要
Project Summary
Our purpose in this project is to illuminate the complexities of the mechanisms regulating erythropoiesis in
man. We believe that there is a pressing need for such a study since erythroid cell development differs in
critical respects from that of most other cells, on which current knowledge largely rests. Erythropoiesis is a
distinctive process in that each mitosis generates daughter cells that are morphologically and functionally
distinct from their parent cell. This has a direct clinical bearing since disordered erythropoiesis, a feature of
several anemias including Diamond-Blackfan Anemia (DBA) and myelodysplastic syndromes (MDS) result
from stage specific defects in erythroid differentiation. In the proposed studies, we will focus on two of the
most important aspects of erythroid differentiation, namely the mechanistic bases regulating erythroid
progenitor generation and terminal erythroid differentiation including enucleation. In order to accomplish these
objectives, we propose two specific aims. In the first aim we hypothesize that erythroid progenitors, BFU-E
and CFU-E, are heterogeneous cell populations characterized by changes in specific gene expression
patterns. Resolving this question will be an essential step towards understanding the molecular basis for
disordered erythropoiesis in DBA as erythroid developmental defects in DBA arise at the progenitor stage.
Our second aim will explore the multifarious mechanisms regulating the expression of anti-apoptotic genes in
polychromatic and orthochromatic erythroblasts and the subsequent induction of mitosis/cytokinesis genes
allowing enucleation of orthochromatic erythroblasts. We hypothesize that deregulation of gene expression at
these developmental stages are responsible for apoptosis of terminally differentiating cells in MDS. We
anticipate that successful accomplishment of the proposed studies will provide novel insights into normal
erythroid cell development as well as into diseases associated with disordered erythropoiesis. The recognition
in recent years of an increasing number of conditions linked to anomalies of erythropoiesis, lend new urgency
to pursue the proposed studies in view of the paucity of effective treatments. We hope and expect that the
research direction we propose may lay the groundwork for developing novel therapeutic strategies.
项目摘要
我们在这个项目中的目的是阐明调节红细胞生成机制的复杂性,
伙计我们认为,由于红系细胞的发育在不同的发育阶段是不同的,因此迫切需要进行这种研究。
与大多数其他细胞不同的关键方面,目前的知识主要依赖于这些方面。红细胞生成是
一个独特的过程,因为每次有丝分裂产生的子细胞,在形态和功能上,
与它们的母细胞不同。这有直接的临床意义,因为红细胞生成障碍,
几种贫血包括Diamond-Blackfan贫血(DBA)和骨髓增生异常综合征(MDS
红细胞分化的阶段特异性缺陷。在拟议的研究中,我们将集中研究其中两项
红细胞分化的最重要方面,即调节红细胞分化的机制基础,
祖细胞生成和终末红细胞分化,包括去核。为了完成这些
我们提出了两个具体目标。在第一个目标中,我们假设红系祖细胞BFU-E
和CFU-E,是以特异性基因表达变化为特征的异质细胞群
模式.解决这一问题将是理解这些疾病的分子基础的重要一步。
DBA中的红细胞生成障碍是由于DBA中的红细胞发育缺陷出现在祖细胞阶段。
我们的第二个目标是探索在肿瘤细胞中调节抗凋亡基因表达的多种机制。
多染性和正染性成红细胞以及随后诱导有丝分裂/胞质分裂基因
允许正染性成红细胞去核。我们假设,基因表达的失调,
这些发育阶段负责MDS中终末分化细胞的凋亡。我们
预计拟议研究的成功完成将为正常的
红系细胞发育以及与红细胞生成紊乱相关的疾病。识别
近年来,与红细胞生成异常相关的疾病越来越多,
鉴于缺乏有效的治疗方法,继续进行拟议的研究。我们希望并期待,
我们提出的研究方向可能为开发新的治疗策略奠定基础。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Mohandas Narla其他文献
Mohandas Narla的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Mohandas Narla', 18)}}的其他基金
Diamond-Blackfan Anemia and Ribosomal Protein S19
Diamond-Blackfan 贫血和核糖体蛋白 S19
- 批准号:
6951169 - 财政年份:2004
- 资助金额:
$ 29.12万 - 项目类别:
Diamond-Blackfan Anemia and Ribosomal Protein S19
Diamond-Blackfan 贫血和核糖体蛋白 S19
- 批准号:
7111141 - 财政年份:2004
- 资助金额:
$ 29.12万 - 项目类别:
Diamond-Blackfan Anemia and Ribosomal Protein S19
Diamond-Blackfan 贫血和核糖体蛋白 S19
- 批准号:
7277845 - 财政年份:2004
- 资助金额:
$ 29.12万 - 项目类别:
Diamond-Blackfan Anemia and Ribosomal Protein S19
Diamond-Blackfan 贫血和核糖体蛋白 S19
- 批准号:
6876252 - 财政年份:2004
- 资助金额:
$ 29.12万 - 项目类别:
Diamond-Blackfan Anemia and Ribosomal Protein S19
Diamond-Blackfan 贫血和核糖体蛋白 S19
- 批准号:
7475103 - 财政年份:2004
- 资助金额:
$ 29.12万 - 项目类别:
相似国自然基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
- 批准号:LBY21H010001
- 批准年份:2020
- 资助金额:0.0 万元
- 项目类别:省市级项目
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
- 批准号:81703335
- 批准年份:2017
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
- 批准号:81670594
- 批准年份:2016
- 资助金额:58.0 万元
- 项目类别:面上项目
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
- 批准号:81470791
- 批准年份:2014
- 资助金额:73.0 万元
- 项目类别:面上项目
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
- 批准号:81301123
- 批准年份:2013
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
- 批准号:81101529
- 批准年份:2011
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
- 批准号:39500043
- 批准年份:1995
- 资助金额:9.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Spatial Restriction of Apoptotic Machinery during Neuronal Apoptosis and Pruning
神经元凋亡和修剪过程中凋亡机制的空间限制
- 批准号:
10596657 - 财政年份:2021
- 资助金额:
$ 29.12万 - 项目类别:
Spatial Restriction of Apoptotic Machinery during Neuronal Apoptosis and Pruning
神经元凋亡和修剪过程中凋亡机制的空间限制
- 批准号:
10417219 - 财政年份:2021
- 资助金额:
$ 29.12万 - 项目类别:
Examining the contribution of apoptosis repressor with caspase recruitment domain (ARC) to the anti-apoptotic effect of endurance training in skeletal muscle
检查具有半胱天冬酶募集结构域 (ARC) 的凋亡抑制因子对骨骼肌耐力训练的抗凋亡作用的贡献
- 批准号:
441952-2013 - 财政年份:2015
- 资助金额:
$ 29.12万 - 项目类别:
Alexander Graham Bell Canada Graduate Scholarships - Doctoral
Understanding the activation of pro-apoptotic Bcl-2 family proteins for the development of modulators of apoptosis
了解促凋亡 Bcl-2 家族蛋白的激活以开发凋亡调节剂
- 批准号:
nhmrc : 1059331 - 财政年份:2014
- 资助金额:
$ 29.12万 - 项目类别:
Project Grants
Examining the contribution of apoptosis repressor with caspase recruitment domain (ARC) to the anti-apoptotic effect of endurance training in skeletal muscle
检查具有半胱天冬酶募集结构域 (ARC) 的凋亡抑制因子对骨骼肌耐力训练的抗凋亡作用的贡献
- 批准号:
441952-2013 - 财政年份:2014
- 资助金额:
$ 29.12万 - 项目类别:
Alexander Graham Bell Canada Graduate Scholarships - Doctoral
Examining the contribution of apoptosis repressor with caspase recruitment domain (ARC) to the anti-apoptotic effect of endurance training in skeletal muscle
检查具有半胱天冬酶募集结构域 (ARC) 的凋亡抑制因子对骨骼肌耐力训练的抗凋亡作用的贡献
- 批准号:
441952-2013 - 财政年份:2013
- 资助金额:
$ 29.12万 - 项目类别:
Postgraduate Scholarships - Doctoral
Apoptotic Osteocytes Promote Chondrocyte Apoptosis via Soluble Factors
凋亡骨细胞通过可溶性因子促进软骨细胞凋亡
- 批准号:
251802 - 财政年份:2012
- 资助金额:
$ 29.12万 - 项目类别:
Studentship Programs
Defining the mechanism(s) by which the cellular inhibitor of apoptosis protein 2 (cIAP2) contributes to early stage atherosclerosis development by directly promoting the participation of key apoptotic pathways within lesion-associated macrophages
确定凋亡蛋白细胞抑制剂 2 (cIAP2) 通过直接促进病变相关巨噬细胞内关键凋亡途径的参与来促进早期动脉粥样硬化发展的机制
- 批准号:
191299 - 财政年份:2009
- 资助金额:
$ 29.12万 - 项目类别:
Operating Grants
ATP release during apoptosis and its relevance to apoptotic cell clearance
凋亡过程中 ATP 释放及其与凋亡细胞清除的相关性
- 批准号:
8075522 - 财政年份:2009
- 资助金额:
$ 29.12万 - 项目类别:
ATP release during apoptosis and its relevance to apoptotic cell clearance
凋亡过程中 ATP 释放及其与凋亡细胞清除的相关性
- 批准号:
7676912 - 财政年份:2009
- 资助金额:
$ 29.12万 - 项目类别: